In our latest HERU Blog post we highlight our involvement in the MATTER trail. The IP5-MATTER trial is looking at 'Metastatic prostate cancer men's Attitudes towards the Treatment of the local Tumour and metastasis Evaluative Research'.
The trial aims to explore the treatment preferences of men with newly diagnosed metastatic prostate cancer. In particular, their preferences around some of the new treatments for metastatic prostate cancer. Our Blog post highlights HERU involvement in developing and conducting a discrete choice experiment (DCE) to identify the men's treatment preferences.